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1 INTRODUCTION
1.1 Signal transduction in eukaryotic cells
Correct transmission of extracellular signals is vital both for unicellular and
multicellular organisms. Stimulation of cells from outside can trigger complic-
ated cascades of signal transduction which result in cellular responses such as
growth, differentiation and movement. These signals can be transduced both
by small molecules, like cyclic AMP, Ca2+ or Ins(1,4,5)P3 and by networks of in-
teracting proteins (Berridge, 1993; Hunter, 1997). Small molecules allow rapid
and often strong amplification of signals, whereas the protein networks offer
better controlled and more precise signalling routes.
In signal transduction the correct sub-cellular localisation of participating
molecules is very important and re-localisation is an essential part of the activa-
tion process. As the signals are coming from outside of the cell and transmitted
by transmembrane receptors, the plasma membrane plays an important role as
a meeting point for signalling proteins. Association with the membrane can
either be direct or indirect. Direct membrane binding of a cytoplasmic protein
is for example achieved by covalent lipid modification of the proteins, which it-
self can be dynamically regulated (Mumby, 1997). Indirect membrane localisa-
tion can occur through specific protein-protein interactions, which can as well
be regulated by covalent protein modification such as phosphorylation.
Phosphorylation of proteins is one of the hallmarks of intracellular sig-
nalling. In higher eukaryotes phosphorylation of tyrosines in particular has a
major role in early events of signal transduction. Phosphorylation can serve
several purposes: enzymes can be regulated by modification of the active site
(and other parts) and phospho-tyrosines serve as docking sites for special-
ised interaction domains, as will be discussed later. Modification of phos-
phatidylinositol lipids has gained wide attention in recent years and kinases
and phosphatases responsible for this are intensively studied (Carpenter and
Cantley, 1996). The role of differentially phosphorylated phosphoinositides is
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not clearly understood, but their role as specific membrane targeting signals is
slowly emerging (Toker and Cantley, 1997).
1.2 Small domains in signal transduction
Signals inside the cells are often transduced by specific protein-protein inter-
actions, which are mediated by a number of small, non-catalytic protein mod-
ules. Networks of interactions bring various proteins together and allow effi-
cient transduction of extracellular stimuli.
Use of small, independent protein domains has allowed nature to use sim-
ilar activation mechanisms by shuffling these domains between different pro-
teins. The use of similar domains in different proteins allows also cross-talk
between signalling pathways and creates the possibility for a protein to parti-
cipate in several different networks. In addition this can create functional re-
dundancy to signalling pathways. Homologous domains can also be used in
cytoskeletal proteins, providing a connection between signal tranduction and
structural regulation of the cell.
A large number of signalling domains have been described in the literature
and in the following discussion the emphasis is given to domains which are
widely distributed in proteins and which share either functional or structural
similarities with PH or WW domains (figure 1.1).
1.2.1 Src homology domains
The Src homology domains 2 (SH2) and 3 (SH3) are among the first signalling
modules described. They were identified as regions outside the catalytic kinase
domain (the SH1 domain) of cytoplasmic protein tyrosine kinases (PTKs) by
sequence homology with other signalling proteins (Mayer et al., 1988; Sadowski
et al., 1986). These domains are also the hallmark of the well characterised Src-
superfamily of PTKs (Superti-Furga and Courtneidge, 1995).
SH2 domains
The SH2 domains are typically found in proteins involved in growth factor sig-
nalling such as PTKs, phospholipase C (PLC) isoforms and adaptor proteins
like GRB2 (Russell et al., 1992). No SH2 domains have been found in yeasts or
plants, which is in correspondence with the lack of tyrosine phosphorylation
in these organisms.
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Figure 1.1 Modular proteins and their domains. Picture was drawn following
the suggestions of Bork et al. (1997) with some modifications and additions.
The SH2 domains interact with phosphorylated tyrosine residues (pY) in
their target proteins. The different SH2 domains distinguish between different
ligand peptides by the sequences surrounding the phospho-tyrosine residue
(Piccione et al., 1993). In particular the sequence following the phospho-
tyrosine is important for specificity (Songyang et al., 1993, 1994). Typically the
SH2 domains show greatest selectivity for residues +1 and +3 1. Only GRB2
SH2 domain has shown clear selectivity in position +2, namely for asparagine
(Gay et al., 1997; Songyang et al., 1994). Dissociation constants for SH2-peptide
interactions are low, in nanomolar range.
The structure of the SH2 domain consists of a central -sheet sandwiched
between two -helices (Waksman et al., 1992). The N- and C-termini are very
close to each other, a feature later found to be common for many other small
domains as well. This feature is believed to facilitate the introduction of these
domains to new proteins without disturbing the existing fold of the host pro-
tein.
All the SH2 domains bind the phospho-tyrosyl residue in a specific pocket
with a strictly conserved arginine B5 interacting with the phosphate group of
1The phospho-tyrosine position is assigned as 0 and other residues are numbered in relation
to it, ie. +3 refers to the 3rd residue C-terminal to pY.
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the phospho-tyrosine and the loop between -strands B and C closing over the
phosphate (Eck et al., 1993; Lee et al., 1994; Rahuel et al., 1996; Waksman et al.,
1992, 1993). In the crystal structures of Src and Lck SH2 domains, the peptide
lies in extended conformation perpendicular to the central -sheet of the SH2
domain and a deep pocket serves as a docking site for a hydrophobic residue
in the position +3 of the peptide (Eck et al., 1993; Waksman et al., 1993). The Syp
SH2 domain binds the phosphopeptides in same orientation as Src and Lck, but
rather than having a specific pocket for the +3 residue, it binds the peptide in
a continuous groove which allows a hydrophobic residue in position +1 (Lee
et al., 1994). These results are in accordance with the different specificities of
these domains for the +1 position; the Src family members prefer glutamate
in this position whereas Syp chooses a hydrophobic residue (Songyang et al.,
1993).
A recent structure of the C-terminal SH2 domain of GRB2 in complex with a
phospho-peptide has revealed an alternative binding mode, where the peptide
adopts a -hairpin conformation and +2 residue interacts specifically with the
domain (Rahuel et al., 1996). GRB2 has the only SH2 domain which discrimin-
ates residues in this position. The different specificity and mode of binding can
be correlated with features of GRB2’s primary structure.
Structure of the tandem SH2 domains from ZAP-70 protein tyrosine kinase
in complex with doubly phosphorylated peptide from the  subunit of the T-
cell receptor has unveiled an interesting mechanism by which multiple do-
mains can co-operate to achieve high specificity and affinity interactions with
their ligands (Hatada et al., 1995). The two SH2 domains are connected by a
65 residue linker which by forming a coiled-coil brings the domains side-by-
side creating a long, continuous binding site for the peptide. Remarkably, the
binding pocket for the second phospho-tyrosine is formed by the interface of
the two SH2 domains. The relative orientation of the two SH2 domains en-
ables highly selective interaction with the natural ligand. The sequence sur-
rounding the two phospho-tyrosines does not affect the specificity of the bind-
ing, whereas correct distance between them is crucial for interaction. Struc-
ture of the tandem SH2 domains of protein tyrosine phosphatase SH-PTP2
shows different inter-domain arrangement and two phosphopeptides bind in-
dividual domains in roughly anti-parallel orientations (Eck et al., 1996b). The
SH2 domains are fixed in their relative positions by a disulfide linkage and
are predicted to restrict both the length and conformation of a natural biphos-
phorylated ligand peptide.
Structure and Function of PH and WW domains 15
SH3 domains
The SH3 domains contain ca. 60 amino acids and are characterised by several
highly conserved aromatic residues. They are more universal than SH2 do-
mains and are found in yeasts, invertebrates and vertebrates (Musacchio et al.,
1992a, 1994b). In addition to typical signalling proteins, the SH3 domains are
also present in cytoskeletal proteins providing a possible link between the sig-
nal transduction pathways and the morphological changes of the cell (Lehto
et al., 1988; Musacchio et al., 1992a).
In 1992 Cicchetti and co-workers identified the first SH3 binding protein,
3BP1. A deletion analysis and site-directed mutagenesis of 3BP1 (and of a
second SH3 binding molecule molecule 3BP2) pinned down a ten amino-acid
proline rich sequence as the binding site for SH3 domains (Ren et al., 1993). A
similar recognition motif has since been confirmed for several different SH3 do-
mains. These peptides can adopt left-handed poly-proline type II (PPII) helical
conformations in solution and they bind to SH3 domains typically with micro-
molar affinities (Viguera et al., 1994).
The structure of the SH3 domain is a five-stranded anti-parallel -barrel
(Musacchio et al., 1992b; Noble et al., 1993; Yu et al., 1992). The most distinct-
ive feature of this domain is the clustering of conserved aromatic residues on
one of its sides. This hydrophobic surface has proved to be the interaction site
for the ligands of SH3 domain.
As predicted before, the proline-rich peptides bind SH3 domain in PPII con-
formation (Musacchio et al., 1994a). The bound peptide interacts with the SH3
domain by intercalating its sidechains into the ladder of aromatic residues on
the surface of the domain. The PPII conformation allows the side-chains of the
peptide to be positioned correctly for this interaction. The interactions between
the proline-rich peptide and SH3 domain are not, however, very specific - a fea-
ture that partly explains the ability of an SH3 domain to interact with several
different peptides, and vice versa, with similar affinities.
The PPII helix is a pseudo-symmetrical structure which allows binding of
peptide ligands to SH3 domains in two opposite orientations. The SH3 domain
of SEM-5, a Drosophila melanogaster orthologue of GRB2, binds the proline-rich
peptide of Sos in an opposite orientation to that of the Abl and Fyn SH3 do-
mains (Lim et al., 1994; Musacchio et al., 1994a). The peptide-domain interac-
tions are very similar in both peptide orientations and the residues outside the
proline-rich core of the peptide determine the orientation of the binding (Lim
et al., 1994).
The structure of Nef-protein from human immunodeficiency virus (HIV) in
complex with R96L mutant of Fyn SH3 domain demonstrates how interactions
outside the PPII helix contribute to the specificity and affinity of the interaction
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(Lee et al., 1996). The SH3 domain binds the proline-rich tail of Nef in a very
similar manner as it binds an isolated peptide. The specificity and higher affin-
ity of the interaction (over 300 fold difference in binding to full-length Nef vs.
proline-rich peptide of Nef) is governed by interactions between other parts of
the molecules. The so-called RT-loop of the SH3 domain in particular interacts
very specifically with the Nef protein.
The latest twist to the SH3 domain - peptide interactions was revealed by
the crystal structures of Src and Hck tyrosine kinases (Sicheri et al., 1997; Xu
et al., 1997). These structures describe the kinases in the inactive (or closed)
state, which is caused by intramolecular interactions of SH2 and SH3 domains.
The SH2 domain interacts with the inhibitory phospho-tyrosine in the very C-
terminus of the kinase (Y527 in Src) as was known earlier. The SH3 domain
binds the linker between the SH2 and kinase domains and sandwiches it in PPII
conformation against the upper lobe of the kinase. This linker is variable in se-
quence between the Src-like kinases and does not carry the consensus elements
for classical SH3 ligands. But given the functional similarities between the Src
kinases, this inhibitory mechanism is believed to be their common feature. The
SH3 domain was known before to be essential for inhibition of Src, but the
mechanism by which it acts is somewhat surprising (Superti-Furga et al., 1993).
Time will show if more ligands will be found, which, despite the lack of pro-
lines, bind to SH3 domains in the PPII conformation.
1.2.2 Pleckstrin homology domains
The pleckstrin homology (PH) domains were originally identified as an in-
ternal repeat in pleckstrin (also called as p47), a phospho-protein from blood
platelets (Haslam et al., 1993; Mayer et al., 1993; Tyers et al., 1988). The initial
discovery of the domain soon led to more extensive database searches and to
date more than 100 PH domains in different proteins have been identified (Gib-
son et al., 1994; Musacchio et al., 1993; Saraste and Hyvo¨nen, 1995).
The PH domains have ca. 100 amino acids, but some domains can also con-
tain large insertions including several other domains. The PH domains are very
poorly conserved and typical pairwise identities between different domains are
in the range of 10–20 %. The only highly conserved residue is the nearly invari-
ant tryptophan in the C-terminus of the domain. A multiple sequence align-
ment of representative PH domains is shown in the figure 1.2.
The low sequence conservation between PH domains makes the database
searches very difficult and sophisticated profile searches are needed in order
to identify more distant members of the family and still some might be missed
(for an example on phospholipase C s, see Parker et al., 1994).
                                                                                                                                                                                              :         
         BTK_HUMAN LESIFLKRSQQKKK----------TSPLNFKKRLFLLT--------VHKLSYYEYDFERGRR--------GSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEG---------------------PLYVFSP------TEELRKRWIHQLKNVIR
         BMX_HUMAN LEELLLKRSQQKKK----------MSPNNYKERLFVLT--------KTNLSYYEYDKMKRG----------SRKGSIEIKKIRCVEKVNL---------------------EEQTPVERQYPFQIVYKDG---------------------LLYVYAS------NEESRSQWLKALQKEIR
        IGBP_HUMAN LLLFMIKRAQGRKR----------FGMKNFKKRWFRLT--------NHEFTYHKSKGD-------------QPLYSIPIENILAVEKLEEE------------------------SFKMKNMFQVIQPER---------------------ALYIQAN------NCVEAKDWIDILTK-VS
        RASGAPB_HU KEGEMYKRAQGRTR----------IGKKNFKKRWFCLT--------SRELTYHKQPGSK------------DAIYTIPVKNILAVEKLEES------------------------SFNKKNMFQVIHTEK---------------------PLYVQAN------NCVEANEWIDVLCRVSR
         PLCD1_RAT KGSQLLKVKSS-----------------SWRRERFYKLQ-----EDCKTIWQESRKVMRS-----------PESQLFSIEDIQEVRMGHRTEGLEKFAR----------------DIPEDRCFSIVFKDQR-------------------NTLDLIAP------SPADAQHWVQGLRKIIH
       PLCB1_BOVIN KGTKFVKWEDDS----------------TVVTPIILRTD------PQGFFFYWTDQNK-----------------ETELLDLSLVKDARCGKHAKAPK-----------------DPKLRELLDVG-NIGR--LEHRMITVVYGPDLVNISHLNLVAF------QEEVAKEWTNEVFSLAT
        PIPA_DROME TTGCVFDRWFENEKETK---------ENDFERDALFKVD------EYGFFLYWKSEGR--------------DGDVIELCQVSDIRAGGTPKDPKILDKV---------------TKKNGTNIPELDKRS---------LTICSNTDYINITYHHVICP-----DAATAKSWQKNLRLITH
       PLCG1_HUMAN VMTLFYSKKSQRPERKT------------FQVKLETRQ-----------ITWSRGADKIEG--------------AIDIREIKEIRPGKTSRDFDR------------YQEDPAFRPDQSHCFVILYGM---------------------EFRLKTLSLQ--ATSEDEVNMWIKGLTWLME
        PLD1_HUMAN IEGMIMKRSGGHRIPGLNCC-GQGRACYRWSKRWLIVK--------DSFLLYMKPDSGAI-------------AFVLLVDKEFKIKVGKKETET-------------------------KYGIRIDNLSR----------------------TLILKCN-----SYRHARWWGGAIEEFIQ
    SPECTRIN_MOUSE MEGFLNRKHEWEAHNKK-------ASSRSWHNVYCVIN--------NQEMGFYKDAKSAASG------IPYHSEVPVSLKEA-ICEVALDYKKKK-------------------------HVFKLRLSDG--------------------NEYLFQAK------DDEEMNTWIQAISSAIS
      HUMAN_SPECBM MEGYLGRKHDLEGPNKK-------ASNRSWNNLYCVLR--------NSELTFYKDAKNLALG------MPYHGEEPLALRHA-ICEIAANYKKKK-------------------------HVFKLRLSNG--------------------SEWLFHGK------DEEEMLSWLQGVSTAIN
    SPECTRIN_DROME HEGYVTRKHEWDSTTKK-------ASNRSWDKVYMAAK--------AGRISFYKDQKGYKSN----PELTFRGEPSYDLQNA-AIEIASDYTKKK-------------------------HVLRVKLANG--------------------ALFLLQAH------DDTEMSQWVTSLKAQSD
      DYNAMIN1_RAT RKGWLTINNIGIM--------------KGGSKEYWFVLT-------AENLSWYKDDEEKEK------------KYMLSVDNL-KLRDVEKGFMSSK------------------------HIFALFNTEQRN-------------VYKDYRQLELACE------TQEEVDSWKASFLRAGV
  PLECKSTRIN_HUMAN REGYLVKKGSVFNT---------------WKPMWVVLL--------EDGIEFYKKKSDNSP------------KGMIPLKGS-TLTSPCQDFGKRM------------------------FVFKITTTKQ---------------------QDHFFQAA-----FLEERDAWVRDINKAIK
PLECKSTRIN/2_HUMAN FRGVIIKQGCLLKQGHRR---------KNWKVRKFILRE------DPAYLHYYDPAGAED------------PLGAIHLRGCVVTSVESNSNGRKS---------------------EEENLFEIITADE---------------------VHYFLQAA-----TPKERTEWIKAIQMASR
        AKT1_HUMAN KEGWLHKRGEYIKT---------------WRPRYFLLKN-------DGTFIGYKERPQDVD------------QREAPLNNF-SVAQCQLMKTERP----------------------RPNTFIIRCLQW----------------------TTVIERTFH-VETPEEREEWTTAIQTVAD
         AKT_DICDI HEGFLTKEGGGFKS---------------WKKRWFILKG--------GDLSYYKTKGELVP------------LGVIHLNTSGHIKNSDRKK--------------------------RVNGFEVQTPSR----------------------TYFLCSE-----TEEERAKWIEILINERE
      B-ARK1_HUMAN MHGYMSKMGNPFLTQ--------------WQRRYFYLF--------PNRLEWRGEGEAP--------------QSLLTMEEIQSVEETQIKE---------------------------RKCLLLKIRGG---------------------KQFILQCD-----SDPELVQWKKELRDAYR
        GPK1_DROME LHGYIKKLGGSFASL--------------WQTKYAKLY--------PNRLELHSESGNNK-------------PELIFMDQVEDISSDFILHKN-------------------------ENCIQIRINDGTR------------------DGRIILTNS-----DEIGLKEWSSSLRSAHK
       TIAM1_HUMAN VKNFLVHKKNKKVESATRRK---------WKHYWVSLK--------GCTLFFYESDGRSGID----HNS--IPKHAVWVENS-IVQAVPEHPKK-------------------------DFVFCLSNSLG---------------------DAFLFQTT-----SQTELENWITAIHSACA
         LFP_HUMAN HDGCLLWKTATGR----------------FKDVLVLLM--------TDVLVFLQEKDQKYIF----PTLD--KPSVVSLQNL-IVRDIANQE---------------------------KGMFLISAAPP--------------------EMYEVHTAS------RDDRSTWIRVIQQSVR
         LBC_HUMAN RDGSVFLKNAAGR----------------LKEVQAVLL--------TDILVFLQEKDQKYIF----ASLD-QKSTVISLKKL-IVREVAHEE---------------------------KGLFLISMGMTDP------------------EMVEVHASS------KEERNSWIQIIQDTIN
        SOS1_HUMAN MEGTLTRVGAK------------------HERHIFLFD---------GLMICCKSNHGQPRL-------PGASNAEYRLKEK-FFMRKVQINDKDDTNEY-------------------KHAFEIILKD---------------------ENSVIFSAK-----SAEEKNNWMAALISLQY
         OST_MOUSE VKELARF-KPM-------------------QRHLFLHEK---------AVLFCKKREENGEG----YEKAPSYSYKQSLNMT-AVGITENVKGDT-------------------------KKFEIWYNAR--------------------EEVYIIQAP-----TPEIKAAWVNEIRKVLT
        VAV1_HUMAN IDGELKITSVERRS---------------KMDRYAFLL--------DKALLICKRRGDSYD-----------LKDFVNLHSFQVRDDSSGDRDNK----------------------KWSHMFLLIEDQG--------------------AQGYELFFK-----TRELKKKWMEQFEMAIS
       SEC71_HUMAN REGWLLKLGGGRVKT--------------WKRRWFILT--------DNCLYYFEYTTDKE------------PRGIIPLENL-SIREVEDSKK--------------------------PNCFELYIPDNKDQVIKACKTEADGRVVEGNHTVYRISAP-----TPEEKEEWIKCIKAAIS
        YMX4_CAEEL REGWLFKQSSNPLFSGALS----------WKKRWFVLS--------ENCLYYFDQMTDKE------------PKGIITLANV-GIRKVEAPSRP--------------------------FMFEIFSLSDGQIK--ACKTEQDGRLVEGRHSIYKICAV-----NDEDMRSWINAISRMMA
         TYL_HUMAN KHGALVRKVHADPDCRKTPR-----GKRGWKSFHGILK---------GMILYLQKEEYKPG----------KALSETELKNAISIHHALATRASDYS--------------------KRPHVFYLRTADW---------------------RVFLFQAP-----SLEQMQSWITRINVVAA
    MYELPROT_HUMAN KMGWLKKQRSIVKN---------------WQQRYFVLR--------AQQLYYYKDEEDTK------------PQGCMYLPGC-TIKEIATNPEE-----------------------AGKFVFEIIPASWDQN--------------RMGQDSYVLMAS-----SQAEMEEWVKFLRRVAG
        OXYB_HUMAN REGWLFKWTNYIKG---------------YQRRWFVLS--------NGLLSYYRSKAEMRH----------TCRGTINLATA-NITVEDSCN------------------------------FIISNGG---------------------AQTYHLKAS-----SEVERQRWVTALELAKA
        3BP1_MOUSE KAGYLHKKGGTQLQLLK------------WPLRFVIIH--------KRCIYYFKSSTSAS------------PQGAFSLSGYNRVMRAAEETTSNN-----------------------VFPFKIIHISKKH-------------------RTWFFSAS-----SEDERKSWMAFVRREIG
        GAP1_HUMAN CSGWLRKSPPEKKLKRYA-----------WKRRWFVLRSGRLTG-DPDVLEYYKNDHAKK------------PIRIIDLNLCQQVDAGLTFNKKE---------------------FENSYIFDINTIDR----------------------IFYLVAD-----SEEEMNKWVRCICDICG
         DOS_DROME YEGWLIKSPPTKRIWRAR-----------WRRRYFTLKQGEIP--EQFCLEYYTDHNCRK------------LKGVIDLDQCEQVDCGLRLENRKQK---------------------FQYMFDIKTPKR----------------------TYYLAAE-----TEADMRDWVNCICQVCH
         LL5_MOUSE CRGYLIKMGGKIKS---------------WKKRWFVFDR------LKRTLSYYVDKHETK------------LKGVIYFQAIEEVYYDHLRSAAKSP--------------------NPALTFCVKTHDR----------------------LYYMVAP-----SAEAMRIWMDVIVTGAE
    DGK_ETA_RODENT KEGQLLKQTSSFQR---------------WKKRYFKLR---------GRTLYYAKDSKS------------LIFDEVDLSDASVAEASTKNAN---------------------------NSFTIITPFR----------------------RLMLCAE-----NRKEMEDWISSLKSVQS
     CENTAURIN_RAT KEGYMEKTGPKQTEG--------------FRKRWFTMD--------DRRLMYFKDPLDAFARG--------EVFIGSKESGY-TVLEGLP-PSTQSHH--------------------WPHGITIVTPDR----------------------KFLFTCE-----TESDQREWIAAFQKVVD
           RASGRF2 KRGFLSKKAAEASR---------------WHEKWFALY--------QNVLFYFEGEQSGR------------PAGMYLLEGCSCERTPAPPRTNAGPAG-------------ARDALDKQYYFTVLFGHDGQ-------------------KPLELRCE-----EEQAGKEWMEAIHQASY
        BOI2_YEAST FSGWMSKKGSGAMST--------------WKTRFFTLH--------GTRLSYFSSTTDTR------------ERGLIDITAHRVVPAKEDDKLVSLYAASTG---------------KGRYCFKLLPPQPGSKKG----------LTFTQPRTHYFAVD-----NKEEMRGWMAALIKTTI
       CADAB_MOUSE HSGYLWTIGKNVWKR--------------WKKRFFVLVQ-------VSQYTFAMCSYREKKA---------EPQELLQLDGY-TVDYTDPQPGLEG-----------------------GRAFFNAVKEG---------------------DTVIFASD-----DEQDRILWVQAMYRATG
         GAP_HUMAN KKGYLLKKGKGKR----------------WKNLYFILEG------SDAQLIYFESEKRATK-----------PKGLIDLSVC-SVYVVHDSLFGR------------------------PNCFQIVVQHFSEEH-----------------YIFYFAGE-----TPEQAEDWMKGLQAFCN
        BUD4_YEAST KEGYLLQDGGDLKG--------------KIENRFFKLHG-------SQLSGYHEISRKAK-----------IDINLLKVTKVLRNEDIQADNGGQRN---------------FTDWVLFNECFQLVFDDGER-------------------ITFNAEC------SNEEKSDWYNKLQEVVE
        YAUA_SCHPO KEGLLLVFGATELGTDLAMVS-----KAAWHKHWIVVE--------NGSLWEYANWKDSVK----------SNVSSISLKHASADKVRKQGR---------------------------RFCFEVVTPK-----------------------LKRLYQAT----SAEEMDSWIEAICEAAK
        IRS1_HUMAN KVGYLRKPK-------------------SMHKRFFVLRAASEAG-GPARLEYYENEKKWRHK-------SSAPKRSIPLESCFNINKRADSKN--------------------------KHLVALYTRD----------------------EHFAIAAD-----SEAEQDSWYQALLQLHN
        AFAP_CHICK ICAFLLRKKRF----------------GQWTKLLCVIK--------ENKLLCYKSSKDQQ------------PQMELLLNDCSITYIPKDSKKK-------------------------KHELKISHQG---------------------ADALVLAVQ-----SKEQAEQWLKVIKDVCS
        KOL3_YEAST KEGWISYKVDGLFSFL-------------WQKRYLVLN--------DSYLAFYKSDKCNEE-----------PVLSVPLTSITNVSRIQLK----------------------------QNCFEILRATDQKENIS---PINSYFYESNSKRSIFISTR-----TERDLHGWLDAIFAKCP
        CLA4_YEAST KSGWVSYKDDGILSFI-------------WQKRYLMLH--------DSYVALYKNDKQNDD-----------AILKIPLTSIISVSRTQLK----------------------------QYCFELVRCSDRNSVSSGSSSSLNVSSDSNSKKSIYIATK-----TESDLHSWLDAIFAKCP
        INT1_ALPHA FEGYLHQEGGDCPI---------------FKKRFFKLMG-------TSLLAHSEISHKTR------------AKINLSKVVDLIYVDKENIDRSNHRN--------------FSDVLLLDHAFKIKFANG----------------------ELIDFCAP----NKHEMKIWIQNLQEIIY
        YHV5_YEAST SGWLYMKTTVGHDPKR-----------VVWVRRWCFLQ--------NNVFGVFSLSPSKT----------YVEETDKFGILWITVEYLPKEPR--------------------------NFCFKLRIQNPNCKTE-----------EENTYIDIILQAE-----SIDELKSWINTLTSHKR
        SIP3_YEAST KSGWLYMKTQVGKPTRE-----------IWVRRWCFLK--------NAVFGMFLLSPSKT----------YVEETDKFGVFLTNVRYDPEEDR--------------------------KFCFEVKIFGNKVTEAHDNMSK---------DITLVFQTS-----NYLDLKSWLIAFEATKK
        NUM1_YEAST VIGEYLFKYYPRLGPFG---------FESRHERFFWVHP------YTLTLYWSASNPILEN---------PANTKTKGVAIL-GVESATDPNPYPTG--------------------LYHKSIVVTTET----------------------RTIKFTCP-----TRQRHNIWYNSLRYLLQ
        YKM1_CAEEL QEIALGKSGKRN----------------NWEDRWAVLC--------RRSLYLCVESPAYT------------TEKTIELGSHTRVDVCNAIVDIAYDWLSSS--------------FSKQRHVVRIVTQNR--------------------SEHLIELN-----TESEMLSWISVLQSSSE
        NRKA_TRYBB HRGHVNKLGGGNGKS--------------WKPRFLQIV--------RGQLILTDDEEGNN-------------PKGLNLEQVQGACPVPHSTAKR------------------------DFVFALNTVGG---------------------KGMWFQAV-----SHGDMEMWVHAIQRGIG
        NRKB_TRYBB HRGHVNKLGGGNGKS--------------WKPRFLQIV--------RGQLILTDDEEGNN-------------PKGLNLEQVQGACPVPYSTAKR------------------------DFVFALNTVGG---------------------EGMWFQAV-----SHGDMEMWVHAIQRGIG
        ROCK-I_RAT IEGWLSVPNRGNIKR------------YGWKKQYVVVS--------SKKILFYNDEQDKEQS---------SPSMVLDIDKLFHVRPVTQGDVYR---------------------AETEEIPKIKVSYDVTS-----------------ARDMLLLAC-----SQDEQKKWVTHLVKKIP
        CTRO_MOUSE HLGWMKVPRNNKRGQQG------------WDRKYIVLEG-------SKVLIYDNEAREAGQRPV-EEFELCLPDGDVSIHGAVGASELANTAKAD-----------------------VPYILKMESHPHTTCWP---------------GRTLYLLAP-----SFPDKQRWVTALESVVA
        MI10_CAEEL MEGFLYLKSDGRKS---------------WKKHYFVLR--------PSGLYYAPKSKKP------------TTKDLTCLMNLHSNQVYTGIGWEKKYKS--------------------PTPWCISIKLTALQMKRS-------------QFIKYICAE-----DEMTFKKWLVALRIAKN
       GRB14_HUMAN IHGFLHAKEQGKKS---------------WKKIYFFLR---------RSGLYFSTKGTSKE-----------PRHLQFFSEFGNSDIYVSLAGKKK----------------HGAPTNYGFCFKPNKAGGPR-------------------DLKMLCAE-----EEQSRTCWVTAIRLLKY
        TRIO_HUMAN SQGELILQESFQVWDPKTLI-R-----KGRERHLFLFE---------MSLVFSKEVKDSSG-----------RSKYLYKSKLFTSELGVTEHVEG-----------------------DPCKFALWVGRTPTS-----------------DNKIVLKAS-----SIENKQDWIKHIREVIQ
        CRAC_DICDI IKGDVSYSSIMKKAGGNG---------KGFLDRYFALH--------RNYILYYKLGKSSLK-----PDDKQEPQGYINLMDCNPDDTKEIAPL----------------------------MFQISHKHR----------------------TYIVKAK-----DESSMKQFLTLLIARIR
        YNE7_YEAST KSGFLEKRSKFLKS---------------YSRGFYVLT--------PSFLHEFKTPDKHKFS---------TPLMSIPLVEC-TVTEHSKKTKSNSE--------------------QGKNKFILRTNSNGLIHR---------------GHNWVFKVD-----SYDDMIEWFGNIKALSS
        KF1A_MOUSE KKGYLHFLEPHTAG---------------WAKRFVVVR--------RPYAYMYNSDKDTV------------ERFVLNLSTA-QVEYSEDQQAMLK----------------------TPNTFAVCTEHR----------------------GILLQAN-----SDKDMHDWLYAFNPLLA
        YBX9_YEAST CSGILYTKVKKKKLFNR----------AKWQKFNVELT--------NTSFNLYSFKTGKL-------------KKSIKLDKIIDCIELDNNSKMK----------------------NDDTNFALITFDE----------------------RLSFKAA-----NDQDMVDWIINFKSGIL
        MIG2_HUMAN LADYIKVFKPKKLTLKG------------YKQYWCTFK--------DTSISCYKSKEESSG----------TPAHQMNLRGCEVTPDVNISGQK------------------------FNIKLLIPVAEG--------------------MNEIWLRCD-----NEKQYAHWMAACRLASK
       GRB10_HUMAN IQGFLQVKEVGRKS---------------WKKLYVCLR---------RSGLYYSTKGTSKE-----------PRHLQLLADLEESSIFYLIAGKKQ------------------YNAPNEHGMCIKPNKAKT----------------EMKELRLLCAE-----DEQIRTCWMTAFRLLKY
    RHOTEKIN_MOUSE ASGALRVQQAGELQN--------------GTLVHGVLKG-------TNLFCYWRSEDADTGQ---------EPLFTIVINKETRVRAGELEQAP-----------------------EWPFTLSISNKYGDD------------------EVTNTLQLE-----SREALQNWMEALWQLFF
    B1_SYNTR_HUMAN HLGWLAEKVPGESKK-------------QWKPALVVLT--------EKDLLIYDSMPRRKE-------AWFSPVHTYPLLATRLVHSGPGKGSPQ---------------------AGVDLSFATRTGTRQG------------------IETHLFRAE-----TSRDLSHWTRSIVQGCH
      RHOGAP_CHICK MEGYLYVQEKRHFGTS-------------WVKHYCTYQR------ESKRITMVPFDQKSGG-----------KGGEDEAVILKSCTRRKTDSIEK------------------------RFCFDVEAVDR--------------------PGVITMQAL-----SEEDRRLWMEAMDGREP
 P115_RHOGAP_HUMAN HEGPLTWRVTKDKAVEVH--------VLLLDDLLLLLQR-------QDERLLLKSHSRTLTP---------TPDGKTMLRPVLRLTSAMTREVATD-----------------------HKAFYVLFTWDQE------------------AQIYELVAQ-----TVSERKNWCALITETAG
        KPCM_HUMAN KEGWMVHYTSKDTL---------------RKRHYWRLD--------SKCITLFQNDTGSR------------YYKEIPLSEILSLEPVKTSALIPNG--------------------ANPHCFEITTANVVYYVGENVVNP-----SSPSPNNSVLTSG----VGADVARMWEIAIQHALM
             ruler 1.......10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.
Figure 1.2 Multiple sequence alignment of PH domains. The sequences are coloured according to conservation. Hy-
drophobic residues are on blue background, negatively charged on purple, prolines on yellow, positively charged on
red, glycines on brown and serines and threonines on green.
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Distribution of PH domains
The PH domains are found throughout the animal kingdom and in yeasts—no
PH domain has been detected in plants or in bacteria (Musacchio et al., 1993;
Gibson et al., 1994). The proteins carrying PH domains are either involved in
signal transduction or they are part of the cytoskeleton. The PH domains oc-
cupy variable positions in proteins, as demonstrated by pleckstrin, which has
PH domains both in the extreme N- and C-termini separated by a so-called
DEP domain (This domain is found in proteins like dishevelled, egl-10 and pleck-
strin, Ponting and Bork, 1996). The PH domain containing proteins are typic-
ally modular, ie. they are composed of various independent domains (Saraste
and Hyvo¨nen, 1995). The PH domains seem independent of other domains.
However some domains are always found next to a PH domain. The Dbl ho-
mology domain (DH, also called Cdc24 or RhoGEF domain), a guanine nuc-
leotide exchange factor of small G-proteins of Rho and Rac families, is always
followed by a PH domain (Cerione and Zheng, 1996). Another such example
is the Btk motif which is in all cases preceded by a PH domain (Vihinen et al.,
1994).
Structure of PH domains
The first three-dimensional structures determined of PH domains were the N-
terminal PH domain of human pleckstrin and the domain of murine -spectrin,
both by NMR (Macias et al., 1994; Yoon et al., 1994). After these the structures
of dynamin, PLC1, -spectrin (both from mouse and fruit fly), Sos-1 and BTK
PH domains have been solved either by X-ray crystallography or NMR (I;III;
Koshiba et al., 1997; Downing et al., 1994; Ferguson et al., 1994; Fushman et al.,
1995; Timm et al., 1994; Ferguson et al., 1995; Zhang et al., 1995b).
The structure of the PH domain consists of a seven-stranded -sandwich
which is capped by a C-terminal -helix. The conserved tryptophane in the C-
terminus of the domain is part of the hydrophobic core. Similar to SH3 and SH2
domains, the N- and C-termini of PH domains are very close in space, facilit-
ating the insertion of this domain into new proteins. The topology of the PH
domain and the structure of the -spectrin PH domain are shown in figure 1.3.
The different PH domains share the same fold, but differ greatly in the vari-
able loops connecting the -strands. A superpositioning of Btk, PLC1, -
spectrin, dynamin and pleckstrin PH domain structures in figure 1.4 illustrates
this feature. The variable loops play an important role in ligand interactions of
PH domains and introduce functional variability to this family, as will be dis-
cussed later. The loops can also carry additional secondary structure elements,
such as the short -helices in the loop 3-4 of -spectrin and loop 5-6 of PLC1
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Figure 1.3 Topology and structure of the PH domains. The -sheets are
numbered from 1-7 both in the topology diagram and in the ribbon represent-
ation of the -spectrin PH domain. The additional -helix in the -spectrin
PH domain is not displayed in the topology diagram. Figure B and all the fol-
lowing protein images are prepared with Molscript (Kraulis, 1991).
and Btk PH domains.
Another common feature shared by the PH domains for which the three-
dimensional structures have been determined is their striking electrostatic po-
larisation. The positively charged end of the domain is the area for inositol
phosphate binding as demonstrated by the crystal structures of PLC1 and -
spectrin PH domains in complex with Ins(1,4,5)P3 (I; Ferguson et al., 1995). In
addition NMR studies with dynamin, pleckstrin and Sos1 PH domains have
localised the binding site for inositol phosphates in this part of the molecules
(Koshiba et al., 1997; Harlan et al., 1995; Zheng et al., 1996a; Salim et al., 1996).
Although this polarisation is very pronounced in the known structures, it
is not a general property of all the PH domains. In a recent homology model-
ling study Blomberg and Nilges (1997) have divided PH domains in different
categories depending on their electrostatic properties. Groups of PH domains
were identified which are either very weakly polarised or have reversed polar-
ity to that described above. These domains are likely to have different function
and/or ligands compared to the ones studied in detail until now.
20 1.2 Small domains in signal transduction
Figure 1.4 Superpositioning of the PH domains. In A the smoothed C traces
of superimposed Btk (purple), -spectrin (yellow), dynamin (green), PLC1
(red) and pleckstrin (light blue) PH domains are shown. In B the most con-
served hydrophobic residues from the same structures are shown as ball-and-
stick models. Colouring is the same as in A. The secondary structure elements
of the Btk PH domain are shown in grey.
Ligands of PH domains
Unlike other widespread signal transduction domains like SH2 and SH3, the
PH domains do not seem to be directly involved in protein-protein interactions.
Instead, the ligands for a large fraction of PH domains are membrane-bound in-
ositol phospholipids and/or their soluble head-group derivatives (figure 1.5).
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Figure 1.5 Chemical formulas of some of the inositol phosphates that bind to
PH domains. In the lipid form, the R is a diacyl glycerol (DAG) group
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In 1993 an N-terminally truncated form of phospholipase C 1 was shown
to have reduced affinity for PtdIns(4,5)P2 containing membranes, although it
was still catalytically active (Cifuentes et al., 1993; Yagisawa et al., 1994). 2 The
truncated enzyme showed impaired processivity, which implied that elements
outside to the catalytic core of the enzyme are required to keep PLC1 on the
membrane. This deletion had occurred in the middle of the yet unidentified
PH domain. Later studies have shown that this domain is required both for
processive catalysis of the enzyme and for membrane association of PLC1 in
vivo (Paterson et al., 1995).
The first direct evidence for PH domain-lipid interaction came from studies
of the N-terminal PH domain of pleckstrin (Harlan et al., 1994). The pleckstrin
PH domain bound specifically to vesicles containing PtdIns(4,5)P2 and this in-
teraction could be inhibited by excess of soluble Ins(1,4,5)P3. The residues
showing chemical shift changes in NMR spectra upon ligand binding were
mapped to -strands 1 and 2 and to loop between -strands 3 and 4 (loop 3-
4). The binding site was later confirmed by site-directed mutagenesis and a
dissociation constant of 13.5 M for PH domain PtdIns(4,5)P2 interaction was
determined (Harlan et al., 1995).
The -spectrin PH domain binds soluble inositol phosphates with compar-
able affinity (I). It binds both Ins(1,4,5)P3 and Ins(1,3,4,5)P4 and a derivative
of PtdIns(4,5)P2, L--glycero-phospho-D-myo-inositol (4,5) bisphosphate. The
PLC1 PH domain has the highest known affinity to Ins(1,4,5)P3 with an estim-
ated dissociation constant (K
D
) of 210 nM (Lemmon et al., 1995). Affinity for
corresponding lipids is slightly lower. Several other PH domains have since
been shown to bind inositol phosphates; they are listed in table 1.2.2.
The structures of -spectrin and PLC1 PH domains in complex with
Ins(1,4,5)P3 are known and will be discussed later in detail (I and Ferguson
et al., 1995).
Increasing amount of in vivo data is emerging supporting the role of PH do-
mains as membrane anchors. In cells pleckstrin is associated with membranes
and this association requires an intact N-terminal PH domain (Ma et al., 1997).
Interestingly, phosphorylated serines just downstream of this domain are reg-
ulating this interaction. The C-terminal PH domain does not affect the mem-
brane association and its function is not known. Dbl, a DH domain containing
protein, depends on the PH domain for membrane association and requires it
to retain oncogenic activity (Zheng et al., 1996b). Related protein Tiam-1 is re-
cruited to membrane by the first of its two PH domains, but in contrast to Dbl,
the PH domain next to DH domain can be deleted without noticable effect on
cellular localisation of the protein (Michiels et al., 1997). Rapid endocytosis me-
2The nomenclature used for the phosphoinositides follows that suggested by Divecha and
Irvine (1995). For abbreviations, see page 10.
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Protein Ligand KD Reference
pleckstrin PtdIns(4,5)P2 13.4 M Harlan et al. (1995)
PLC1 Ins(1,4,5)P3 210 nM Lemmon et al. (1995)
PLC1 PtdIns(4,5)P2 1.09 M Lemmon et al. (1995)
dynamin PtdIns(4)P 1.8 M Zheng et al. (1996a)
dynamin PtdIns(4,5)P2 1.23 mM Salim et al. (1996)
-spectrin g-PIns(4,5)P2 40 M I
Akt/RAC PtdIns(3,4)P2 400 nM Frech et al. (1997)
SOS1 PtdIns(4,5)P2 1.8 M Kubiseski et al. (1997)
Btk Ins(1,3,4,5)P4 40 nM Fukuda et al. (1996)
Btk PtdIns(3,4,5)P3 800 nM Rameh et al. (1997)
Gap1m Ins(1,3,4,5)P4 40 nM Fukuda and Mikoshiba (1996)
p130 Ins(1,4,5)P3 12.2 M Takeuchi et al. (1996)
Table 1.1 The table shows inositol phosphate ligands for isolated PH do-
mains and their estimated dissociation constants. (In addition the PH do-
mains of Tsk, pleckstrin C-terminus and Ras-GAP have been reported to bind
PtdIns(4,5)P2 containing vesicles, but little or no data for the specificity or af-
finity have been presented (Harlan et al., 1994)).
diated by dynamin-1 requires intact PH domain and can be blocked by exo-
genous dynamin-1 PH domain (Artaljo et al., 1997). This effect is specific for
this isoform and is mediated by two amino acids which are different between
the PH domains of dynamin 1 and 2. GTPase activity of dynamin is also activ-
ated by PtdIns(4,5)P2 (Salim et al., 1996; Lin and Gilman, 1996). The N-terminal
PH domain is required (but not sufficient), for Ca2+ mediated membrane target-
ing of Ras-GRF (Buchsbaum et al., 1996). PH domain is indispensible for effect-
ive signalling between insulin receptor and insulin receptor substrate 1 (IRS-1)
(Myers Jr. et al., 1995). Its deletion abolishes tyrosine phosphorylation of IRS-1
and decouples it from downstream signalling (Yenush et al., 1996). The proto-
oncogene Akt is one of the only proteins that are known to be directly regulated
by phosphoinositide 3-OH-kinase (PI3K) (Kaplan and Cantley, 1997). Akt car-
ries a PH domain in its N-terminus and depends on this domain for activation
by PtdIns(3,4)P2 (Franke et al., 1997; Klippel et al., 1997). The Akt is also claimed
to form homo-oligomeric complexes through its PH domain and adjacent re-
gion (Datta et al., 1995; Franke et al., 1997). The guanine nucleotide exchange
factors of the small G-protein ARF1 (containing a so-called Sec7 domain and a
PH domain) also bind to membranes and phosphoinositide vesicles with their
PH domains (Chardin et al., 1996; Klarland et al., 1997). The Sos PH domain is
localized to specific areas of the plasma membrane, namely the leading edge, in
serum-induced fibroblasts (Chen et al., 1997). Surprisingly this was independ-
ent of the PtdIns(4,5)P2 binding capasity, pointing to existence of additional
Structure and Function of PH and WW domains 23
membrane bound ligands or binding partners for PH domains. Microinjected
Sos PH domain has dominant-negative effect on Sos dependent signalling, sug-
gesting that it can compete with the endogenous protein for its ligands.
The most often mentioned protein ligands for PH domains are the -
subunits of trimeric G-proteins. In -adrenergic receptor kinase (-ARK),
a serine-threonine protein kinase responsible for the desensitisation of -
adrenergic receptor, a PH domain and its C-terminal extension interact with
-subunits. This interaction localises -ARK to plasma membrane and activ-
ates the kinase (Koch et al., 1993). This activation can be further enhanced by the
presence of PtdIns(4,5)P2 in the lipid vesicles carrying the -subunits (Pitcher
et al., 1995). Some other PH domains have also been shown to interact with
the -subunits, but the interactions described are often weak and require ele-
ments outside the PH domain (Touhara et al., 1994; Wang et al., 1994; Tsukada
et al., 1994).
PH domains in disease
Bruton’s tyrosine kinase is a cytoplasmic protein kinase of the Tec-family,
which is affected in hereditary immunodeficiency, X-linked agammaglobu-
linemia (XLA) (Vetrie et al., 1993; Tsukada et al., 1993). Inactivation of Btk by
XLA mutations ceases the maturation of B-cells to pre-B-cell stage. As a res-
ult of this the patients have very low levels of circulating B-cells and immun-
oglobulins in their blood and are very vulnerable to infectious diseases (Smith
et al., 1994).
Large number of XLA mutations have been detected throughout the mo-
lecule including several point mutations in the PH domain (Vihinen et al., 1996).
A Btk PH domain mutation R28C is also the cause of a similar disease, x-linked
immunodeficiency (xid), in mice (Rawlings et al., 1993; Thomas et al., 1993).
Analysis of XLA mutations in Btk can provide information on the function of
individual domains in Btk and to the maturation process of B-cells in general.
XLA (and xid) is the only inherited disease, which is caused by muta-
tions in the PH domain The Btk PH domain binds specifically Ins(1,3,4,5)P4
and PtdIns(3,4,5)P3 (table 1.2.2) and molecular reasons for inactivation of Btk-
mediated signal transduction by mutations in this domain will be discussed
later.
1.2.3 Phosphotyrosine binding domains
The phosphotyrosine binding (PTB, also called PID or SAIN) domains are a
second class of domains in addition to SH2 domains that specifically recog-
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nise phosphorylated tyrosines in their target proteins. The PTB domain was
first discovered in the N-terminus of an adaptor molecule Shc for it’s capacity
to interact with tyrosine-phosphorylated proteins (Blaikie et al., 1994; van der
Geer et al., 1995; Gustafson et al., 1995; Kavanaugh and Williams, 1994). Se-
quence database searches using the experimentally defined PTB domain of Shc
revealed the presence of PTB in 13 other proteins (Bork and Margolis, 1995).
The PTB domains share very low sequence homology and for example the IRS-
1 was never detected in database searches, although it is known from functional
and structural studies to carry this domain.
The substrate specificity of PTB domains differs from that of SH2 domains.
While the SH2 domains distinguish between different peptides from the se-
quence C-terminal to the phospho-tyrosine, the PTB domains differentiate the
peptides by their N-termini. The Shc PTB domain recognises a consensus mo-
tif NPXpY in the target proteins c-ErbB2, EGF and IL4 receptors (Gustafson
et al., 1995; Kavanaugh et al., 1995). The IRS-1 and Shc PTB domains recognise
slightly different phosphotyrosine peptides which vary in the positions -1 , -
5 and -6 with respect to phosphotyrosine (Tru¨b et al., 1995). Dissociation con-
stants of PTB domains for peptides derived from their biological binding part-
ners can be as low as 20 nM (Zhou et al., 1995a).
Structures of both Shc and IRS-1 PTB domains in complex with ligand pep-
tides are known. The structure of Shc PTB domain was solved by NMR in com-
plex with a peptide from nerve growth factor receptor TrkA (Zhou et al., 1995b).
The structure of IRS-1 domain has been solved by NMR in complex with IL4 re-
ceptor peptide and by X-ray crystallography in complex with insulin receptor
peptide (Eck et al., 1996a; Zhou et al., 1996). A surprising feature of the PTB do-
mains is their close structural similarity to PH domains (figure 1.6). The PTB
and PH domains share the same core of seven-stranded -sandwich capped by
a C-terminal -helix. The Shc PTB domain has an insertion in the first loop con-
taining two additional -strands and an -helix, but the core of the domain is
still the same (Zhou et al., 1995b).
The PTB domains bind their peptide ligands between the C-terminal-helix
and the adjacent -strand 5. The N-terminus of the peptide continues the -
sheet of the domain by hydrogen bonding to the -strand 5. The NPXpY phos-
phopeptides have -turn confirmation in solution and the same confirmation is
retained upon binding to PTB domains (Eck et al., 1996a; Tru¨b et al., 1995; Zhou
et al., 1995b, 1996). The phosphotyrosine residue is coordinated both in Shc and
IRS-1 by positively charged amino acids, which, however, are not equivalent
between the domains. Arginine 67 in Shc PTB comes from the long insertion
which is missing from IRS-1 and also the residues in the -strand 5 and loop
6-7 (numbering corresponds to IRS-1) are different.
The specificity of PTB domains for particular peptides is affected by spacing
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A Shc PTB domain B IRS-1 PTB domain
Figure 1.6 PTB domains of Shc and IRS-1. The secondary structure elements
that correspond to those of PH domains are coloured as in figure 1.3. The in-
sertion between -strands 1 and 2 in the Shc domain is shown in green. The
key residues coordinating the phospho-tyrosine peptide are shown as ball-
and-stick models
of hydrophobic residues in the amino terminus of the ligand. An aliphatic leu-
cine in position -5 binds to a hydrophobic pocket in Shc PTB domain, where as
IRS-1 has a similar hydrophobic interaction with residues in positions -6 and -8
of the peptide.
The similarities with PH domains are further enhanced by the observation
that Shc PTB domain can interact with PtdIns(4,5)P2 vesicles (Zhou et al., 1995b;
Rameh et al., 1997). It will be interesting to see if some of the PH domains could
bind phospho(tyrosine)-peptides as well. However, comparison of SH2 and
PTB domains reveals more differences than common features between these
two domains. In contrast to the SH2 domain, the PTB domain i) recognises the
substrates via the N-terminal end of the peptide, ii) binds the peptide parallel
to the -sheet, iii) binds the the peptides in a -turn conformation and iv) co-
ordinates the phosphotyrosine with variable, non-conserved residues.
1.2.4 WW domains
The WW domain was originally discovered as an additional internal repeat
in murine Yes-kinase associated protein (YAP65), when it was compared with
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chicken and human isoforms (Sudol et al., 1995). The WW domains are among
the smallest signal transduction modules with barely 40 residues. They are
characterised by two fully conserved tryptophans (hence the name WW) and
a proline. The WW domains are found, often in multiple copies, in proteins
with diverse functions such as adaptor protein YAP65, cytoskeletal protein dys-
trophin, transcription-factor activator FE65 and peptidyl-prolyl isomerase Pin1
(Andre´ and Springael, 1994; Bork and Sudol, 1994; Lu et al., 1996). In addition
to animals and yeasts, WW domains are also found in plants (Sudol et al., 1995).
Expression library searches with the WW domain of YAP65 have identified
two putative protein ligands which share a common sequence motif PPPPY
(Chen and Sudol, 1995). This proline-rich sequence is required for interaction
with YAP65 WW domain, but does not seem to bind to WW domain of dys-
trophin (Chen and Sudol, 1995).
The Nedd4 WW domains recognise a similar sequence from the C-terminus
of amiloride-sensitive epithelial sodium channel (ENaC) (Staub et al., 1996).
This interaction is required for regulation of the ion channel’s activity and
mutations or deletions of this proline-rich region are found in patients suffering
from hereditary form of systemic hypertension, the Liddle’s syndrome (Schild
et al., 1996; Staub et al., 1996).
Proline-rich region of formins, nuclear phosphoproteins involved in limb
and renal development, bind several different SH3 and WW containing pro-
teins from -expression libraries (Chan et al., 1996). The WW domains of these
protein (called collectively as formin binding proteins or FBPs) are sufficient to
bind formin. They can compete for the same binding site with various SH3 do-
mains. The two WW domains of FBP11 recognise proteins carrying a consensus
sequence PPLP, but do not bind the YAP WW binding protein with PPxY motif
(Bedford et al., 1997).
Both the PPLP motif binding to FBP11 and the proline-rich region of ENaC
are recognised by SH3 domains of Abl and -spectrin, respectively illustrating
the overlapping ligand binding specificities between these two domain families
(Bedford et al., 1997; Rotin et al., 1994).
The structure of YAP65 WW domain has been solved by heteronucler NMR
and will be discussed later (II).
2 AIMS OF THIS STUDY
This study was initiated after the first structures of PH domains had been de-
termined and information on potential ligands for these domains was begin-
ning to emerge. The aims set for this study were:
 To study the structures of small interaction domains in signalling mo-
lecules.
 To identify ligands of these domains.
 To study the specificity of ligand interaction.
 To characterize these protein - ligand interactions structurally.
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3 MATERIALS AND METHODS
3.1 Cloning, mutagenesis and expression
The domains were amplified from cDNA using polymerase chain reaction
(PCR). Cleavage sites for selected restriction enzymes were included in the PCR
primers. The amplified PCR fragments were digested and cloned into E.coli ex-
pression vectors under T7 promoter (Pera¨nen et al., 1996). All DNA constructs
were verified by dideoxy sequencing. Clonings were carried out in the E.coli
strain DH5. Mutant domains were generated by PCR-directed mutagenesis
and cloned into similar E.coli expression vectors as the wild-type proteins and
sequenced.
The domains and their mutants were expressed in E.coli strain BL21(DE3)
which carries a chromosomal copy of the T7 RNA polymerase (Studier et al.,
1990; Hyvo¨nen and Saraste, 1997). The bacterial cultures were grown at 37C
until the the optical density at 600 nm reached 0.8-1.0 after which the expression
was induced by adding 400 M isopropyl--D-thiogalactopyranoside (IPTG).
If the expression was done at lowered temperature (as was the case with Btk
PH domain -Btk motif), the bacterial cultures were cooled to the desired tem-
perature prior induction. The induction was 3 hours at 37C and 20 hours at
15C.
The proteins were released from E.coli cells by French press lysis and puri-
fied to homogeneity by various chromatographic techniques and analysed by
mass-spectroscopy. The results of the mass-analysis of -spectrin and Btk PH
domains and YAP65 WW domain are shown in table 3.1. The protein concen-
trations were determined spectrophotometrically in 6 M guanidinium chloride
at 280 nm using calculated absorption coefficients (Gill and von Hippel, 1989).
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Domain Calculated Calculated Measured
mass mass (-Met) mass
-spectrin PH domain 12268.86 12137.67 12266.0
Btk PH domain 20084.05 19952.86 19952.9
YAP65 WW domain 6372.10 – 6372.4
Table 3.1: Results of the mass-analysis of the studied domains.
3.1.1 -spectrin PH domain
Part of the mouse general form -spectrin cDNA (genbank:musspna), corres-
ponding to the PH domain (amino acids 2199 - 2304), was cloned to a non-
fusion expression vector pBAT4 and to glutathione-S-transferase (GST) fusion-
vector pGAT2 to generate a GST fusion protein for panning experiments with
phage display libraries.
The -spectrin PH domain was purified by a combination of cation ex-
change, gel filtration and anion exchange chromatographies as described (I).
The resulting protein was very pure and could be stably stored at +4C for
months in 10 mM sodium phosphate pH 6.5. The GST fusion of -spectrin PH
domain was purified using glutathione-Sepharose affinity chromatography as
described before and used immediately (Smith and Johnson, 1988).
3.1.2 Btk PH domain
The human Btk (swissprot:btk human) PH domain-Btk motif was amplified by
PCR from cDNA supplied by Prof. C. I. Edward Smith (Karolinska Institute,
Stockholm). Initial attempts to express the canonical PH domain of Btk alone
resulted in an insoluble protein which resisted all refolding attempts. Only
after the adjacent Btk motif was added to the expression construct, a stable,
soluble protein could be produced. The solubility of different Btk expression
constructs is shown in figure 3.1.
The amino-terminal 170 amino acids of Btk contain altogether 7 arginines
(with two pairs), which are encoded by AGG or AGA, corresponding to 4%
of all the amino acids. The Arg-tRNA for these codons is expressed at very
low levels in E.coli resulting in highly reduced expression of proteins with
high AGG/AGA codon content (Emilsson et al., 1993; Brinkmann et al., 1989).
In addition to greatly lowering the expression of a protein, these codons can
get supressed by lysyl-tRNAs in E.coli leading to heterogeneity of the protein
sample (Calderone et al., 1996). These problems can be solved by overexpress-
ing this Arg-tRNA from a low-copy-number plasmid (Brinkmann et al., 1989).
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Figure 3.1 Solubility of the Btk PH domain - Btk motif expression constructs.
Four different constructs containing either the PH domain alone of both PH
domain and Btk motif were created and their solubility in E.coli was studied
after expression at 15C. The span of the constructs is shown on top of the gel,
the two lanes for each construct represent the total cell lysate (T) and the sol-
uble fractions (S) of the lysate.
This was done in the case of Btk PH domain, as no protein expression could
be detected otherwise. The yield of purified protein expressed in this manner
varied between 10 and 15 mg per litre of E.coli culture.
The protein was purified in three steps using cation exchange and gel fil-
tration chromatographies (III). The concentrated protein was stored frozen at
-80C in 10 mM Tris, 100 mM NaCl, 2 mM DTT pH 8.0 in small aliquots.
3.1.3 WW domain
The WW was cloned from cDNA of human YAP65 (swissprot:ya65 human)
supplied by Prof. Marius Sudol (NYU, Mount Sinai School of Medicine, New
York). Expression of this small domain was possible only when fused to
GST. Several expression constructs were created to define the minimal domain
boundaries. The different constructs and their behaviour during the purifica-
tion and the NMR experiments are shown in table 3.2. The construct 2, corres-
ponding to residues 164-217 of the human YAP65, was used in our studies, as
it was the smallest non-degraded and folded protein. It could be expressed in
soluble form at 37C.
The WW domains were purified using a combination of affinity chroma-
tographies and gel filtration. The soluble fraction of the E.coli cell lysate was
loaded into glutathione-Sepharose column and the column was washed until
no more protein was eluting. The GST-WW fusion protein was eluted with 10
mM reduced glutathione in 100 mM Tris pH 8.5, 2 units of bovine thrombin per
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1 GSM DDVPLPAGW...WQDPRKAMLSQ degraded
2 GSM SFEIPDDVPLPAGW...WQDPRKAMLSQMNVTAPTS folded
3 GS PAGW...WQDPRKAMLSQMNVT degraded
4 GS VPLPAGW...WQDPRKAMLSQMNVT degraded
5 GS VPLPAGW...WQDPRKAMLSQMNVTAPTS unfolded
Table 3.2 WW domain expression constructs. The protein sequences corres-
pond to the final, full-length products after thrombin cleavage from the GST-
fusion. Two to three amino acids from N-terminus (GS or GSM) that are separ-
ated from the rest of the sequence by a space are derived from the expression
vector and are not part of the human YAP65. The sequence between the two
conserved tryptophans has been deleted for clarity.
1 mg of fusion protein was added and the sample incubated overnight in room
temperature. The digested fusion-protein was loaded to Ni2+-NTA column to
which the GST (carrying an N-terminal His6-tag) bound. The released WW do-
main was collected from the flow-through, concentrated and loaded into Su-
perdex 30 gel filtration column. Highly purified domain eluted as a single peak
at ca. 80 ml. The sample was concentrated for NMR to 1mM and D2O was ad-
ded to final concentration of 10 % v/v.
For heteronuclear NMR experiment both C13/N15 and C13/N15/H2 labelled
samples were prepared. The E.coli were grown in M9 minimal media sup-
plemented with 1 g/l of each sugar-mix, peptone and hydrolysate of labelled
Chaenopodium rubrum cells and 10 g/l of N15H4Cl (Ashurst and Oschkinat, un-
published). For the H2 labelling the growth media was prepared in heavy water
(D2O). Otherwise the expression and purification were as with the unlabelled
sample.
3.2 Panning of a phage display library
In an attempt to identify protein ligands for PH domains, the -spectrin PH
domain was used as a receptor for a phagemid library displaying random no-
namer peptides on the pVIII coat protein of a filamentous phage M13 (Felici
et al., 1991). The phage panning was done as described by Smith and Scott
(1993) with some modifications. The main differences were the amplification
of the library, for which we needed to use a helper phage, and the immobilisa-
tion technique for the receptor.
The PH domain was immobilised as GST fusion on glutathione-Sepharose
beads and incubated with the peptide library. Unbound phages were removed
by multiple washes with TBST buffer (20 mM Tris, 150 mM NaCl, 0.1 % Tween-
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20, pH 7.4). The bound phages were eluted with 20 mM glycine-HCl pH 2.5,
neutralised with buffer and used to infect E.coli cells (strain JM101). The infec-
ted cells were plated on ampicillin plates and grown overnight at 37C.
The colonies were scraped from the plates the next day, grown for 2 hours
in liquid culture and infected with a helper phage M13(K07) to package DNA
into phage particles. Infected cultures were grown overnight and produced
phages were purified from the media the next morning. This amplified eluate
was used as a starting material for the next round of panning. This procedure
was repeated three times more lowering the amount of fusion protein in each
round. In the end, 54 independent clones from the last round of panning were
sequenced by single-stranded dideoxy sequencing.
3.3 CD spectroscopy
The binding of -spectrin PH domain and inositol phosphates was studied us-
ing near-UV circular dichroism (CD) spectroscopy as described earlier (I). In
brief, the near UV CD-spectrum of the PH domain was recorded at various con-
centrations of inositol phosphate ligands and ligand-induced changes in the
spectra were used to estimate the binding constants.
3.4 Crystallography
3.4.1 Crystallisation of PH domains
The crystallisation of the PH domain was done using hanging drop vapour dif-
fusion method. The protein solution was mixed with reservoir solution in 1:1
ratio and incubated at 20C.
The initial screening was done using an incomplete factorial screen of 48
different conditions developed by J. Zeelen at EMBL and using commercial
screens from Hampton Research. Promising conditions were then refined until
the best possible crystals were obtained.
The -spectrin PH domain was crystallised from mother liquor containing
10-15 % (w/v) PEG-6000, 30 % ethanol and 100 mM sodium acetate pH 4.8. Ini-
tial protein concentration was 20 mg/ml in 10 mM sodium phosphate pH 6.5.
Ins(1,4,5)P3 was added in 3-fold molar excess before the crystallisation drops
were prepared. Needle-like crystals, which normally developed in 2-3 days,
are shown in figure 3.2A.
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The Btk PH domain - Btk motif was crystallised from 32.5 % PEG-3350, 500
mM NaCl, 200 mM MgCl
2
and 100 mM Tris-HCl pH 8.5. Protein concentra-
tion varied between 6 and 8 mg/ml. The wild-type domain and all the soluble
mutants were used in crystallisation trials. The wild-type protein gave only
very small “balls” of thin needles, shown in figure 3.2B, which were unsuit-
able for X-ray diffraction. Mutant R28C, however, gave high quality plate-like
crystals which diffracted beyond 1.5 A˚ in a synchrotron X-ray source. These
crystals are shown in figure 3.2C.
Figure 3.2 PH domain crystals. In A the crystals of -spectrinPH domain are
shown. The needles had maximum thickness of 0.2 mm and length of up to
3 mm. In panel B are the “needle-balls” of the wild-type Btk PH domain- Btk
motif. In C are the crystals obtained with mutant R28C. The individual plates
were typically ca. 0.5 mm in two dimensions and ca. 50 m thick.
3.4.2 Data collection and processing
The diffraction data collection and processing was done as described earlier (I
and III). All data was collected from frozen crystals at 100–110 K to minimise the
radiation damage to the crystals. For the -spectrin PH domain 10 % glycerol
was used for cryoprotection. The Btk crystals did not need a cryoprotectant
due to high concentration of PEG-3350 in the mother liquor. The synchrotron
dataset of Btk PH domain was collected in two phases. The second phase was
needed to secure reliable low-resolution information, as these reflections were
saturated during the longer exposures of the high resolution data collection.
The high and low resolution data were then merged together omitting all the
saturated reflections. The data collection statistics are summarized in table 3.3.
For the heavy metal derivative searches the crystals of Btk PH domain -
Btk motif were soaked in original mother liquor into which heavy atom com-
pounds had been dissolved, typically at 1 mM concentration. After variable in-
cubation periods a dataset was collected from a soaked crystal and processed
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Dataset Resol.  Rsymm Unique refl. Completeness
-spectrin 1 2.8 A˚ 1.514 A˚ 4.3 % 3261 98.8 %
-spectrin 2 2.0 A˚ 1.514 A˚ 4.7 % 7830 89.6 %
Btk native 1 2.6 A˚ 1.514 A˚ 6.0 % 9817 99.8 %
Btk derivative 2.6 A˚ 1.514 A˚ 6.1 % 9319 97.2 %
Btk native 2 1.6 A˚ 0.882 A˚ 5.4 % 42840 99.9 %
Table 3.3: The data collection statistics.
as with the native crystals. The different datasets of Btk crystals showed vari-
ations in the cell dimensions and were clearly non-isomorphous. To overcome
these problems, the datasets used for the phasing were collected from a single
crystal. After collecting a native dataset the crystal was thawed and soaked for
24 hours in the heavy-atom solution, after which a derivative dataset was col-
lected. The crystals did not suffer from repeated freezing and thawing and the
resulting datasets were isomorphous.
3.4.3 Structure determination and refinement
The phase problem for the -spectrin PH domain was solved by molecular re-
placement using the previously determined NMR structure of the same mo-
lecule as a search model using the programs AMoRe and X-PLOR (Navaza,
1994; Bru¨nger, 1988). The correct solution was found using artificial temper-
ature (B) factors, which were derived from the root-mean-square deviations of
atom positions in the ensemble of the solved NMR structures (for a detailed
description of the method, see Wilmanns and Nilges, 1996).
The Btk PH domain - Btk motif structure was solved by so-called heavy-
atom method. The screening of potential derivatives and phasing was done
using program package Phases-95 (Furey and Swaminathan, 1996). After ex-
tensive searches, a single heavy atom derivative, trimethyl lead (II) acetate, was
found. This proved to have very good phasing power both for isomorphous
and anomalous data and was sufficient to solve the phase ambiguity. Phases
were very good to the resolution limit of the in-house datasets, 2.6A˚.
The phases were improved by solvent flattening and two-fold non-
crystallographic symmetry averaging in program DM (Cowtan, 1994). Later
when high-resolution synchrotron data was available, the experimental phases
were extended to 1.8 A˚.
The model-building was done using the program O (Jones et al., 1991). The
models were refined using programs X-PLOR (Bru¨nger, 1988), TNT (Tronrud
et al., 1987) and ARP (Lamzin and Wilson, 1993) as described (I and III). Refine-
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ment statistics for -spectrin and Btk PH domain are shown in table 3.4. Co-
ordinates of the -spectrin and Btk PH domains have been deposited to Protein
Data Bank (PDB) under accession numbers 1BTN and 1BTK, respectively.
Protein Resol. Rcryst Rfree
-spectrin PH domain 8.0-2.0 A˚ 20.5 % 28.6 %
Btk PH domain 40.0-1.6 A˚ 23.1 % 28.0 %
Table 3.4: Refinement statistics.
The stereochemical quality of the models was analysed using Procheck and
WHAT-Check programs (Laskowski et al., 1993; Vriend, 1990).
3.5 NMR and modelling
The structure of the YAP65 WW domain was determined by heteronuclear
NMR as described (II). The model of the WW domain - proline-peptide
complex was calculated using a simulated anneling protocol with X-PLOR
(Bru¨nger, 1988).
4 RESULTS
4.1 The -spectrin PH domain (I and unpublished)
4.1.1 The ligands of the -spectrin PH domain
One of the original aims in our study was to identify protein ligands for PH do-
mains. So far no ligands were known for the -spectrin (or any other) PH do-
main and as an attempt to find one, we used this domain as a bait for panning a
random peptide library. Similar approach had successfully been used for other
signalling modules, e.g. for the SH3 domains (Sparks et al., 1994; Cheandle
et al., 1994).
After several rounds of binding and amplification of random nona-peptide
phage display library, 54 individual clones were sequenced. Of these, 20 either
carried no insert, contained in-frame stop codons or were too short. The re-
maining peptide sequences were analysed for common motifs and divided into
four groups shown in table 4.1.
group 1 group 2 group 3 group 4
MRRRQPKNL 5 ? DRRAKHLPL 2 ? RRAANPQAR QATSTHHAR
RRVQPKALR 2 ? NKKVKGFAW RKCCSRPRG ARHHSSDQP
AQPRSWDFP HNRRLRDSL ARKAASYPG RNFGVMAVS
AQPRSSHFP KRIKDRVGQ AKRKSSLPR SICPNKTPP
QPKKVKAPL 2 ? NKKARYGPM NRRKFSSES YALKWKPQS
SRRGVPANP KESTCNNPP
ANRKLYYFS SAKSVSATA
HRKKVTEIQ SNFSQIRAL
Table 4.1 The peptides obtained from a nona-peptide library using -spectrin
PH domain as a receptor. The number after the sequence indicates how many
times the same peptide was found in the analysed clones.
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The peptides in the group 1 share a common motif QPK/R. For the second
group a consensus motif KRAK can be derived. Group 3 contains peptides with
consecutive positive residues and group 4 all the rest. As can be seen, the se-
quences are only distantly related even within these groups and no clear con-
sensus pattern can be derived. Peptides marked with a star (?) in table 4.1 were
synthesised and binding to -spectrin PH domain was studied by NMR, CD
and fluorescence spectroscopy, but none of the peptides bound to this domain
even at millimolar concentrations (data not shown). The reasons for this are
unclear. In a control experiment GST was used as a receptor, and the clones se-
quenced in the end showed similarity neither to each other nor to the peptides
obtained with the -spectrin PH domain. The peptides are displayed in tens
or even hundreads of copies on the surface of the phage and it is possible that
multiple weak (and unspecific) interaction can lead to amplification of false-
positive clones. As this attempt to find a protein ligand for the -spectrin PH
domain proved unsuccessful, we turned to inositol phosphates, which were
shown to bind to the pleckstrin PH domain (Harlan et al., 1994).
The ability of -spectrin PH domain to interact with inositol phosphates
was studied using near-UV CD and NMR spectroscopies. Both the CD and
NMR spectra showed changes upon mixing the protein with inositol phos-
phates which carry phosphates in 4- and 5-positions of the inositol ring. These
include Ins(1,4,5)P3, Ins(1,3,4,5)P4 and g-PIns(4,5)P2. The other tested com-
pounds are listed in table 4.2. The results suggest that the -spectrin PH do-
main interacts with 4- and 5-phosphates, and that the binding is unaffected
by the 3-phosphate. The fact that g-PIns(4,5)P2 bound with similar affinity as
Ins(1,4,5)P3 indicates that the 1-phosphate can be derivatised without affect-
ing the binding. This is noteworthy, as in phosphatidylinositol lipids the phos-
phatidyl moiety is attached to the 1-hydroxyl of the inositol. The dissociation
constant for the -spectrin PH domain g-PIns(4,5)P2 complex was estimated to
be ca. 40 M.
Ligand Binding No binding
D-myo-inositol X
Ins(1)P X
Ins(1,4)P2 X
Ins(1,4,5)P3 X
Ins(1,3,4)P3 X
g-PIns(4,5)P2 X
Ins(1,3,4,5)P4 X
Table 4.2 Binding of different phosphoinositides to-spectrin PH domain. See
page 10 for abbreviations.
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The experiments with Ins(1,4,5)P3 and g-PIns(4,5)P2 induced consistent
changes in the NMR spectra of the PH domain and the binding site could be
localised to loops 1-2 and 5-6. To verify the role of individual residues in PH
domain - ligand interactions, site-directed mutagenesis was used to replace the
positively charged amino acids with glutamines in the vicinity of the binding
site. The capacity of the mutant domains to bind g-PIns(4,5)P2 was studied by
CD spectroscopy. As expected, the mutants K8Q, R21Q and K71Q were unable
to bind the ligand. Mutations R7Q, K17Q or K72Q had no effect on the ligand
binding, which is in agreement with the minor shifts these residues showed in
the NMR spectra.
4.1.2 The structure
The -spectrin PH domain was crystallised in complex with Ins(1,4,5)P3. The
crystals diffracted to 2.0 A˚ in an in-house X-ray source and belonged to space-
group P4212 with unit cell parameters a=b=68.9 A˚, c=50.8 A˚, ===90.
The structure of the -spectrin PH domain in complex with Ins(1,4,5)P3
shows no large differences compared to the previously described unliganded
NMR structure (Macias et al., 1994; Nilges et al., 1997). The largest differences
are seen in the loops involved in ligand interactions (figure 4.1).
Figure 4.1 Crystal and NMR structures of the -spectrin PH domain. A stereo
view of the superimposed C-traces of the crystal structure (green) and the
avarage NMR structure (blue) are shown. The ligand binding residues in the
crystal structure are shown in red and the ligand in yellow.
The PH domain binds Ins(1,4,5)P3 between the -strands 1 and 2 and the
loop 5-6. The binding site is a very shallow pocket surrounded by positively
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charged residues. The binding site is created by residues K8, R21, S22, W23,
Y69 and K71. They interact with Ins(1,4,5)P3 through the 4- and 5-phosphates.
The only contact to 1-phosphate is a hydrogen bond from the -hydroxyl group
of S22. There are no contacts to the ring or to the free hydroxyl groups of the
inositol. The binding site in this crystal structure is in perfect agreement with
the ligand specificity studies and localisation of the binding site by NMR spec-
troscopy and site-directed mutagenesis.
4.2 The Btk PH domain (III)
4.2.1 The structure of the Btk PH domain
The wild-type human Btk PH domain and all the soluble mutants were used
for crystallisation attempts.Only the mutant R28C (corresponding to mouse xid
mutation) yielded crystals suitable for diffraction analysis. Crystals belong to
space-group P21 with two molecules in the asymmetric unit. The unit cell di-
mensions are a=49.15 A˚, b=59.87 A˚, c=55.94 A˚, ==90, =98.2. The structure
was solved using a single heavy metal derivative and is refined at 1.6A˚.
The core of the Btk PH domain is very similar to the previously published
PH domains (see figure1.4A for superpositioning of Btk PH domain with the
others). Btk contains a long insertion between the -sheets 5 and 6. The end of
this loop forms a one and a half turn -helix and is part of the interface between
the two molecules in the asymmetric unit. The hydrophilic middle part of the
loop has weak electron density and is left out of the model in one of the two mo-
lecules and is modelled as poly-alanine in the other. In addition to the two pro-
tein molecules, 2 Zn+2 ions (see next section), 2 Na+ ions and 248 waters are in-
cluded in the model. The two Na+ ions are bound between the two protein mo-
lecules in the asymmetric unit with octahedral coordination sphere of protein
or water oxygen atoms (Nayal and Di Cera, 1996). The non-crystallographic
dimer and bound metal ions are shown in figure 4.2.
The structure of the Btk PH domain exposed some errors in the previous
sequence alignments. The first -strand was shifted by one residue which con-
sequently positioned some of the residues in the putative inositol phosphate
binding site incorrectly. In analogy to PLC1 PH domain the Btk PH domain
has a -bulge in the beginning of the -strand 5, which is missing in other
known structures (-spectrin, dynamin and pleckstrin). This -bulge requires
a gap to be opened in the multiple sequence alignment in some cases. These
corrections, although small, are important and as more structural information
accumulates, more accurate database searches can be conducted. A correct se-
quence alignment is also crucial for successful homology modelling of related
domains.
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Figure 4.2 The non-crystallographic dimer of PH domain-Btk motif. The PH
domains are coloured red and green, whereas the Btk motifs are yellow and
blue. The zinc ions are shown in purple and the sodium ions in blue. R28C
mutation is shown as ball- and-stick model.
4.2.2 XLA mutations in the Btk PH domain
We wished to study the structural and functional consequences of XLA muta-
tions in the Btk PH domain and created expression constructs to produce many
of the mutant domains in E.coli. In order to produce the protein in E.coli, it was
necessary to include the adjacent small domain, so-called Btk motif to the ex-
pression constructs.
As predicted, some of the XLA mutations (T33P, V64F and V113D) disrupt
the structure of the domain and the corresponding proteins could not be pro-
duced in soluble form E.coli. The rest of the mutations do not prevent folding
and the proteins were produced for structural and functional studies.
The crystal structure allows us to predict the effect of XLA mutations on
the Btk PH domain. Mutants T33P, V64F and V113D showed impaired ability
to fold in E.coli and structural characterisation of these residues supports our
biochemical data. V64 and V113 are conserved hydrophobic residues which
contribute to the hydrophobic core of the domain and introduction of a bulky
phenylalanine or a polar aspartate would be unfavourable. T33 is located in the
loop 2-3 and a rigid proline is likely to affect the folding and/or conformation
of this part. We have recently expressed also the mutant L11P, which exhibits
similar behaviour in E.coli and can be classified as a folding mutant (data not
shown).
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All the other XLA mutations are located in the putative binding site for
PtdIns(3,4,5)P3 and ipppp (for more detailed discussion on the binding sites see
section 5.1). Mutations K12R and R28H/C/P affect residues whose analogues
in the PLC1 PH domain interact directly with Ins(1,4,5)P3. Mutations S14F and
F25S are predicted to have more indirect effect on inositol phosphate binding.
Impaired binding of Btk PH domain to an phosphoinositol ligand is anticip-
ated to prevent membrane localisation of the kinase during activation causing
a developmental arrest of B-cells and subsequently XLA.
4.2.3 The structure of the Btk motif
In the Tec family of cytoplasmic tyrosine kinases, the PH domain is always
followed in sequence by a short motif which is characterised by conserved
cysteine and histidine residues (Vihinen et al., 1994). This so-called Btk motif
is needed for stability of the Btk PH domain as demonstrated by our failed at-
tempts to express the Btk PH domain alone in E.coli (see figure 3.1 on page 30).
In the progress of building the initial model of the protein into experimentally
derived electron density maps, a metal ion which was bound to the Btk motif
was identified . This metal ion was tetrahedrally coordinated by the conserved
three cysteines and a histidine, suggesting that it could be a zinc ion. Atomic
absorption spectroscopy confirmed that the sample contained 0.94 zinc atoms
per protein molecule. The zinc coordination sphere, bond lengths and angles
are shown in table 4.3.
Bond angles in degrees Bond lengths to Zn+2
H143 N1 C154 S C155 S C165 S Mol. 1 Mol. 2
C165 S 118.0 100.8 110.9 2.2 A˚ 2.2 A˚
C155 S 95.7 123.0 112.9 2.4 A˚ 2.4 A˚
C154 S 109.6 117.2 97.0 2.4 A˚ 2.3 A˚
H143 N1 114.4 101.4 113.8 2.1 A˚ 2.1 A˚
Table 4.3 Zinc coordination in the Btk motif. The table shows the angles
between protein ligands centered on the metal ion. The upper and lower
halves of the table show data of the two different molecules in the asymmetric
unit. The two last columns list the bond lengths between the protein ligands
and the zinc ion.
The Btk motif has a compact, globular core in the middle of which the zinc
is bound. The metal ion is completely buried and keeps the structure together.
The Btk motif packs against the -sheets 5-7 of the PH domain and the aromatic
side-chain of F146 is inserted into a hydrophobic pocket formed by residues
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C155
C154
C165
H143
Figure 4.3 The Btk motif. The figure A shows the coordination of the zinc ion
by residues H143, C154, C155 and C165. Interface between Btk motif and PH
domain is shown B. F146 of the Btk motif (red atoms) and residues forming
the hydrophobic pocket in the PH domain (green atoms) are shown as ball-
and-stick models.
V67, P101, Y112 and F114 (Figure 4.3B). Additional hydrogen bonding stabil-
ises the domain-domain interaction.
The globular part of the Btk motif is connected to PH domain with a 9-
residue linker, which wraps around the edge of the PH domain’s -sheet. The
only conserved residue in the linker is N135. It inserts its N atom into a
small pocket and donates hydrogen bonds to the main chain carbonyl groups
of residues V58 and I61. A multiple sequence alignment of known Btk motifs
and the preceding linkers is shown in the figure 4.4.
4.3 The WW domain of YAP65 (II)
4.3.1 The structure
The structure of the WW domain is very simple—a single three-stranded -
sheet (figure 4.5). The structured core of the domain with only 30 residues is
smaller than predicted from the sequence alignments. Residues outside this
core do not show long- or medium-range nuclear Overhauser effects (NOEs)
apart from I7, which binds to a hydrophobic patch on the domain and stabil-
ises the structure. This explains our failed attempts to produce a shorter folded
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Figure 4.4 Multiple sequence alignment of Btk motifs and and the preceding
linker. The database accession numbers of the sequences are shown on the
right-hand side of the alignment. Zinc binding residues H143, C154, C155 and
C165 are marked on top of the alignment with asterisks.
domain. The position of I7 is not conserved in other WW domains and is con-
sidered to be a specific feature of YAP65 WW domain. In analogy to SH3 do-
mains, some of the conserved hydrophobic residues, including one of the two
tryptophans, are exposed on the surface of the domain.
L30 Y28
W39
Figure 4.5 Structure of the WW domain from human YAP65. The conserved
hydrophobic residues on the surface of the domain are shown as ball-and-
stick models
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4.3.2 Ligand binding
The structure was solved in complex with a proline-rich peptide
GTPPPPYTVG, which is derived from WW domain binding protein 1 (Chen
and Sudol, 1995). This peptide binds to YAP65 WW domain with KD of 47
M as measured by fluoresence spectroscopy. Binding of the peptide induced
chemical shift changes on WW domain (residues Y28, Q35, T36 and W39
showing shifts of > 0.5 p.p.m.) and residues L30, H32 and W39 showed NOEs
to the ligand. These NOEs defined the orientation of the peptide and a struc-
ture of the WW of the complex was calculated using the limited experimental
data available and restraining the peptide into PPII conformation.
In this model the WW binds its ligand on the concave hydrophobic surface.
Prolines P4’ and P5’ (the peptide residues are primed) are in contact with the
conserved W38 and Y7’ is held in a pocket formed by L30 and H32. The hy-
droxyl group of Y7’ is in close vicinity of H32 and Q35 and could form hydro-
gen bonds with either of them.
To confirm the location of the binding site, mutations L30K, H32A and
Q35A of WW domain were created. H32A and Q35A mutants had completely
lost or greatly reduced ability to bind the peptide. Strongest effects were seen
with a short peptide SPPPYTV, which bound to the wild-type protein with a
similar affinity as the longer peptide. Mutant L30K did not bind the short pep-
tide, but bound the longer peptide with slightly higher affinity than wild-type
protein did, for reasons not clearly understood.
Alanine scanning mutagenesis of the PPPPY motif in the shorter peptide
was used study the minimal determinants for the WW domain-peptide inter-
action. The first and the last of the prolines could be mutated without affecting
the binding, whereas the two middle prolines and the tyrosine were strictly re-
quired for the binding.
5 DISCUSSION
5.1 Inositol phosphate binding site in PH domains
Soon after we had determined the structure of -spectrin PH domain-
Ins(1,4,5)P3 complex, Ferguson et al. (1995) published the structure of PLC1
PH domain - Ins(1,4,5)P3 complex. The PLC1 PH domain bound the ligand
with polar interactions to 4- and 5-phosphates exposing the 1-phosphate to the
solvent. This is very similar mode of binding as was observed for the -spectrin
PH domain. The unexpected finding was the different location of the bind-
ing sites in these two domains. The -spectrin PH domain binds the ligand
between the -strands 1-2 and 5-6 where as in the PLC1 domain the binding
site is located on the other side of -strands 1 and 2 and additional residues
involved in binding reside in the loop 3-4. Although -strands 1 and 2 are in-
volved in both binding sites, the key residues for the ligand interactions are
different as shown in the alignment in figure 5.1. This part of PH domains is
generally rich in positive residues and many PH domains show conservation
of the major ligand binding residues.
The residues in loops 3-4 and 5-6 are very variable and it is more difficult
to predict how the domains would bind inositol phosphates, if they bind at all.
The structures of these loops also differ greatly, further complicating the pre-
dictions.
The structure of the Btk PH domain shows strong similarities with the lig-
and binding residues of the PLC1 PH domain in the -strands 1 and 2. Many
of XLA mutations in the Btk PH domain which are located around the putative
inositol phosphate binding site are known to impair the domains ability to bind
Ins(1,3,4,5)P4 (Fukuda et al., 1996). The differences in the binding sites of PLC1
and Btk PH domains binding sites most likely reflect their preference for differ-
ently phosphorylated ligands (PtdIns(4,5)P2 vs. PtdIns(3,4,5)P3). The mutation
R28C in our structure might have also affected the structure of the binding site
in the vicinity of the mutated residue and only structural characterisation of the
45
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Figure 5.1 Inositol phosphate binding sites in PH domains from -spectrin
and PLC1. The two domains are shown in same the orientation and the lig-
ands are displayed as ball-and-stick models.A multiple sequence alignment of
the -strands 1 and 2 is shown on the top. The residues interacting with the
ligands are highlighted. The residues highlighted in pleckstrin, dynamin and
Sos1 sequences are those that have shown changes in NMR spectra upon ad-
dition of a ligand. The residues on gray background are the most conserved
hydrophobic positions in each -strand.
wild type Btk PH domain can elucidate the details of the ligand binding.
5.2 The ligands of the PH domains
Although many PH domains can bind inositol phosphates, it is still to be seen,
whether these are the physiological ligands for all members of this family. Dif-
ferent forms of phosphoinositides are formed in cells as a result of activation
by extra-cellular signals. The best studied system is the release of Ins(1,4,5)P3
Structure and Function of PH and WW domains 47
by phospholipase C in response to activation of trimeric G-proteins (Berridge,
1993). The soluble Ins(1,4,5)P3 molecules bind to specific receptors in the en-
doplasmic reticulum and trigger the release of Ca2+ into the cytoplasm. The
key enzymes in this cascade, the phospholipases, carry an N-terminal PH do-
main. In this case it is very easy to understand the role of PH domain, which
anchors PLCs to the membrane close to the pool of hydrolysable substrates.
Whether these soluble inositol phosphates are also ligands for PH domains of
either PLCs themselves allowing feed-back regulation of their activity or other
proteins in vivo, remains to be seen.
Many other PH domain carrying proteins are not so clearly or directly in-
volved in the biology of phosphoinositides. Most of these proteins are, how-
ever, closely associated with membranes in cells. -spectrin is a major compon-
ent of the cortical cytoskeleton and is believed to be involved in organisation of
the plasma membrane (Bennet and Gilligan, 1993). The C-terminal part of the
general form of -spectrin carrying the PH domain binds to alkaline washed
bovine brain membranes (Davis and Bennett, 1994; Wang and Shaw, 1995). The
erythrocyte isoform -spectrin lacks PH domain as result of differential spli-
cing and the corresponding region does not interact with membranes. The -
spectrin PH domain is targeted to plasma membrane also in vivo (Wang et al.,
1996).
Many of the kinases carrying PH domains (for example -ARK, Btk, Akt)
associate with membranes following activation and are found in the insol-
uble fraction of the cell lysate, but the molecular mechanism of such transloca-
tion is not well established. Assuming that these PH domains do bind phos-
phatidylinositol lipids in vivo, the availability of the lipid in the membrane
could affect the localisation of these proteins. Phosphoinositide-3-OH kinase
(PI3K) is an enzyme that catalyses the synthesis of various 3-phosphorylated
phosphoinositides and it is activated by various extracellular stimuli (Van-
haesebroeck et al., 1996). Btk and Akt PH domains show highest affinity to-
wards 3-phosphorylated phosphoinositides and are belived be become mem-
brane associated in responce to PI3K activity (Franke et al., 1997; Klippel et al.,
1997; Rameh et al., 1997; Salim et al., 1996). Regulated synthesis and rapid
turnover of these lipids could be used to regulate membrane association of PH
domain carrying proteins (figure 5.2. For reviews see Toker and Cantley, 1997;
Carpenter and Cantley, 1996; Franke et al., 1997).
In this scenario, the role of PH domains is very much the same as with
many other signalling domains - they bring the proteins to the site of action.
A membrane bound protein is restricted in its movements to two dimensions,
a limitation which would greatly facilitate interactions with other membrane
bound proteins. The co-operative activation of -ARK by -subunits and
PtdIns(4,5)P2 is a good example of such a coordinated action of lipid and pro-
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Figure 5.2 Phosphoinositide metabolism in signal transduction. Figure adap-
ted from Toker and Cantley (1997), which should also be referred to for more
details.
tein components in the membrane (Pitcher et al., 1995).
Covalent lipid modification is a common way to enhance the membrane loc-
alisation of signalling proteins (Casey, 1995; Bhatnagar and Gordon, 1997). The
Ras proteins are isoprenylated and often also palmitoylated in their C-terminus
and many members of Src PTK family are myristoylated in the N-terminus, to
give some examples. In some cases lipid modification and PH domain seem
to carry an analogous function. -ARK is closely related to rhodopsin kinase
(RK), and both can desensitise rhodopsin by phosphorylation. The two pro-
teins differ most in their C-termini, as the PH domain is missing and is replaced
by an isoprenylation signal in RK. The functional analogy between the PH do-
main and lipid modification is demonstrated by restoration of function in C-
terminally deleted -ARK by isoprenylation (Koch et al., 1993). Another such
example is lfc, a member of DH domain containing proteins, in which trans-
formation capacity can be restored by substituting PH domain for isoprenyla-
tion signal of Ras, suggesting a membrane anchoring function for this class of
PH domains (Whitehead et al., 1995). In Tiam1, however, the PH domain ad-
jacent to DH domain is not required for membrane association, but instead an
additional PH domain in the N-terminus localises the protein to membrane and
can be substituted with myristoylation signal of c-Src (Michiels et al., 1997).
Src and Btk are another example of homologous proteins which have altern-
atively either lipid modification or a PH domain, in this case in their very N-
termini. Both of these enzymes are translocated to membrane upon activation,
but experiments similar to those with -ARK and RK have not yet been done.
Lipid modifications and PH domains seem to share the same principal func-
Structure and Function of PH and WW domains 49
tion of membrane targeting, but allow different ways to control this localisation
of proteins—both spatially and temporally. Cellular membranes have areas en-
riched in specific lipids (sphingolipids and cholesterol, in particular), which
can serve as localisation sites for various proteins including doubly lipidated
PTKs (Simons and Ikonen, 1997). These so-called membrane rafts are also en-
riched in PtdIns(4,5)P2 and some of the phosphoinositide-modifing enzymes
providing a possible docking site also for PH domains (Hope and Pike, 1996).
The role of PH domain as a regulated membrane targeting module is well
exhibited in Btk. As some point mutations in the PH domain can cause XLA by
abolishing binding to inositol phosphates and preventing membrane recruit-
ment of Btk, others can enhance the membrane association of the kinase and
constitutively activate it (Li et al., 1995).
5.3 Structure and function of the Btk motif
The Btk motif is a new zinc-binding domain with no clear homologies in the
Protein Data Bank. The zinc coordination by three cysteines and a histidine is
found also in diacyl glycerol/ phorbolester binding domain (DAG/PE), LIM
domains and some zinc fingers, but none of them coordinate the metal ion with
two adjacent cysteines. These other domains form a tight turn similar to that
in the Btk motif at the zinc site, but they have typically two residues between
the coordinating cysteines (Pe´rez-Alvarado et al., 1994; Zhang et al., 1995a).
The function of the Btk motif is unknown. It is always found adjacent to a
PH domain and as our structure shows, these two domains are closely associ-
ated. The sequence conservation of the Btk motif is restricted to two glycines in
addition to the zinc coordinating residues. The role of the glycines is unclear.
They do not have phi-psi angles in the disallowed region of the Ramachandran
plot, which could structurally explain their conservation. A possibility is that
these flexible amino acids are required during the folding of this small motif.
Especially the second glycine (G164 in Btk) could have such a role as it is posi-
tioned just before the last zinc liganding cysteine. The possibility that these gly-
cines are functionally important residues cannot be ruled out either. The first
of these glycines (G150 of Btk) is on the “top” of the Btk motif, when viewed as
in figure 4.2, lying next to the side-chain of W147. This residue is partly mobile
and has its sidechain partly solvent exposed.
A recently discovered Btk associated protein BAP-135 binds specifically to
Btk, more precisely to amino-terminal fragment of Btk containing PH domain
and Btk motif (Yang and Desiderio, 1997). BAP-135 is not similar to any other
known proteins and it is not known which part of it interacts with Btk.
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5.4 WW domain
The function of WW domain as an adaptor module with functional similarity
with SH3 domains is getting established. The recognition motifs for WW and
SH3 domains are very similar and in many cases these domains can compete
for the same ligands (Bedford et al., 1997; Sudol, 1996b). WW domains are very
often present in multiple copies in proteins; Nedd4 protein carries four WW
domains in a row. Binding of several domains to a long proline-rich sequence in
the target protein would increase the affinity of the protein-protein interaction
and allow more specific targeting of these proteins.
In Pin1 protein the WW domain is associated with a peptidyl-prolyl iso-
merase domain, which catalyses cis-trans isomerisation of proline residues (Lu
et al., 1996). A likely function of WW domain is to attach the enzyme to a
proline-rich substrate enhancing the catalytic activity in a very similar manner
as the PH domains do in phospholipase Cs.
Involvement of WW domain containing proteins in several human diseases
like Alzheimer’s disease (FE65), Liddle’s syndrome (Nedd4) and muscular
dystrophies (dystrophin) has been implied (Sudol, 1996a). Only in the case of
Liddle’s syndrome evidence for the possible involvement of WW domain in the
development of the disease has been presented and further studies are required
to establish the role of WW domains in other diseases.
5.5 Conclusions
In this study the structures and ligand interactions of -spectrin and Btk PH do-
mains as well as the YAP65 WW domain have been characterised. The results
bring insight to the function of these domains as molecular adaptors.
The -spectrin PH domain binds to inositol phosphates with 40 M affin-
ity recognising specifically the 4- and 5-phosphates of the ligands. The bind-
ing site for the Ins(1,4,5)P3 is located between -strands 1 and 2 and the loop
5-6. The ligand is coordinated by polar residues in the middle of the positively
charged end of the domain. Orientation of Ins(1,4,5)P3 on the -spectrin PH
domain has lead us to propose a model, where PH domain acts as a membrane
targeting module recognising a membrane bound phospholipid, PtdIns(4,5)P2,
specifically. The membrane interaction is strengthened by additional, unspe-
cific interactions between the positively charged surface of the PH domain and
the negatively charged lipid headgroups. Spectrin is a large cytoskeletal pro-
tein located just under the plasma membrane and the PH domain is believed to
serve as a direct membrane anchor of the protein. Further studies are needed
to assess the biological role of these interactions.
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The structure of the Btk PH domain and Btk motif has allowed us to pre-
dict the molecular mechanism of XLA in the cases where the disease causing
mutations are located in the PH domain. Some of the XLA mutations affect
the fold of the domain preventing the assembly of the native three-dimensional
structure. Other mutations affect surface exposed residues which are localised
around the predicted binding site for inositol phosphates. Comparison of the
Btk PH domain with the Ins(1,4,5)P3 binding site in the PLC1 PH domain has
enabled us to predict the role each of the mutated residues in XLA. The struc-
ture of the Btk motif has revealed a novel zinc binding fold. A zinc ion is bound
inside the Btk motif to three conserved cysteines and a histidine stabilising the
structure. The Btk motif is tightly associated with the PH domain, and they are
predicted to form a functional entity. This structure provides a rational basis
for further studies on the role of PH domain and Btk motif in XLA, in the mat-
uration of B-cells and signal transduction in general.
The structure of the WW domain from human YAP65 has been solved in
complex with a proline-rich peptide by NMR. The structure of the WW do-
main is a single three-stranded -sheet. Some of the conserved, hydrophobic
residues of the WW domain are exposed on the surface of the domain forming
a binding site for a proline-rich peptide. The WW domain is predicted to bind
its ligand in a PPII helical conformation and model of the complex based on the
available experimental data is presented. The binding site has been confirmed
by mutagenesis of both the WW domain and the ligand peptide.
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